The Initial Commitments set out the Parties’ proposal to divest Chr. Hansen’s G2
Project and its existing lactase distribution business together with the Novozymes lactase production facility where [proportion] of Novozymes and Chr. Hansen’s lactase products are currently produced (the "Divestment Business").